• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非冠状动脉粥样硬化:冠状动脉旁路移植术患者预后不良的一个标志物。

Non-coronary atherosclerosis: a marker of poor prognosis in patients undergoing coronary artery bypass surgery.

作者信息

González-Lorenzo Óscar, Franco Pelaez Juan A, Kallmeyer Andrea, Nieto Luis, Esteban Laura, Pello Ana, Aceña Álvaro, Aldamiz Gonzalo, Tuñón José

机构信息

Department of Cardiology, IIS-Fundación Jiménez Díaz, Madrid, Spain.

Faculty of Medicine, Autónoma University, Madrid, Spain.

出版信息

Front Cardiovasc Med. 2024 Feb 23;11:1305162. doi: 10.3389/fcvm.2024.1305162. eCollection 2024.

DOI:10.3389/fcvm.2024.1305162
PMID:38464841
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10921089/
Abstract

INTRODUCTION

The presence of non-coronary atherosclerosis (NCA) in patients with coronary artery disease is associated with a poor prognosis. We have studied whether NCA is also a predictor of poorer outcomes in patients undergoing coronary artery bypass grafting (CABG).

MATERIALS AND METHODS

This is an observational study involving 567 consecutive patients who underwent CABG. Variables and prognosis were analysed based on the presence or absence of NCA, defined as previous stroke, transient ischaemic attack (TIA), or peripheral artery disease (PAD) [lower extremity artery disease (LEAD), carotid disease, previous lower limb vascular surgery, or abdominal aortic aneurysm (AAA)]. The primary outcome was a combination of TIA/stroke, acute myocardial infarction, new revascularization procedure, or death. The secondary outcome added the need for LEAD revascularization or AAA surgery.

RESULTS

One-hundred thirty-eight patients (24%) had NCA. Among them, traditional cardiovascular risk factors and older age were more frequently present. At multivariate analysis, NCA [hazard ratio (HR) = 1.84, 95% confidence interval (CI) 1.27-2.69], age (HR = 1.35, 95% CI 1.09-1.67,  = 0.004), and diabetes mellitus (HR = 1.50, 95% CI 1.05-2.15,  = 0.025), were positively associated with the development of the primary outcome, while estimated glomerular filtration rate (HR = 0.86, 95% CI 0.80-0.93,  = 0.001) and use of left internal mammary artery (HR = 0.36, 95% CI 0.15-0.82,  = 0.035), were inversely associated with this outcome. NCA was also an independent predictor of the secondary outcome. Mortality was also higher in NCA patients (27.5% vs. 9%,  < 0.001).

CONCLUSIONS

Among patients undergoing CABG, the presence of NCA doubled the risk of developing cardiovascular events, and it was associated with higher mortality.

摘要

引言

冠心病患者中非冠状动脉粥样硬化(NCA)的存在与预后不良相关。我们研究了NCA是否也是冠状动脉旁路移植术(CABG)患者预后较差的预测因素。

材料与方法

这是一项观察性研究,纳入了567例连续接受CABG的患者。根据是否存在NCA分析变量和预后,NCA定义为既往中风、短暂性脑缺血发作(TIA)或外周动脉疾病(PAD)[下肢动脉疾病(LEAD)、颈动脉疾病、既往下肢血管手术或腹主动脉瘤(AAA)]。主要结局是TIA/中风、急性心肌梗死、新的血运重建手术或死亡的组合。次要结局增加了LEAD血运重建或AAA手术的需求。

结果

138例患者(24%)存在NCA。其中,传统心血管危险因素和高龄更为常见。多因素分析显示,NCA[风险比(HR)=1.84,95%置信区间(CI)1.27 - 2.69]、年龄(HR = 1.35,95% CI 1.09 - 1.67,P = 0.004)和糖尿病(HR = 1.50,95% CI 1.05 - 2.15,P = 0.025)与主要结局的发生呈正相关,而估计肾小球滤过率(HR = 0.86,95% CI 0.80 - 0.93,P = 0.001)和左乳内动脉的使用(HR = 0.36,95% CI 0.15 - 0.82,P = 0.035)与该结局呈负相关。NCA也是次要结局的独立预测因素。NCA患者的死亡率也更高(27.5%对9%,P < 0.001)。

结论

在接受CABG的患者中,NCA的存在使发生心血管事件的风险增加一倍,且与更高的死亡率相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d36f/10921089/114d8f4c69f3/fcvm-11-1305162-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d36f/10921089/614efdec67af/fcvm-11-1305162-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d36f/10921089/29fef9439f8d/fcvm-11-1305162-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d36f/10921089/114d8f4c69f3/fcvm-11-1305162-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d36f/10921089/614efdec67af/fcvm-11-1305162-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d36f/10921089/29fef9439f8d/fcvm-11-1305162-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d36f/10921089/114d8f4c69f3/fcvm-11-1305162-g003.jpg

相似文献

1
Non-coronary atherosclerosis: a marker of poor prognosis in patients undergoing coronary artery bypass surgery.非冠状动脉粥样硬化:冠状动脉旁路移植术患者预后不良的一个标志物。
Front Cardiovasc Med. 2024 Feb 23;11:1305162. doi: 10.3389/fcvm.2024.1305162. eCollection 2024.
2
[Comparison on the long-term outcomes post percutaneous coronary intervention or coronary artery bypass grafting for bifurcation lesions in unprotected left main coronary artery].[经皮冠状动脉介入治疗或冠状动脉旁路移植术治疗无保护左主干冠状动脉分叉病变的长期预后比较]
Zhonghua Xin Xue Guan Bing Za Zhi. 2017 Jan 25;45(1):19-25. doi: 10.3760/cma.j.issn.0253-3758.2017.01.005.
3
Left Main Revascularization With PCI or CABG in Patients With Chronic Kidney Disease: EXCEL Trial.左主干血运重建经皮冠状动脉介入治疗或冠状动脉旁路移植术治疗慢性肾脏病患者: EXCEL 试验。
J Am Coll Cardiol. 2018 Aug 14;72(7):754-765. doi: 10.1016/j.jacc.2018.05.057.
4
[Outcome analysis of patients undergoing percutaneous coronary intervention with or without prior coronary artery bypass grafting operation].[接受或未接受过冠状动脉旁路移植术的患者经皮冠状动脉介入治疗的结果分析]
Zhonghua Xin Xue Guan Bing Za Zhi. 2017 Jul 24;45(7):559-565. doi: 10.3760/cma.j.issn.0253-3758.2017.07.003.
5
[Efficacy comparison of 3 strategies for real-world stable coronary artery disease patients with three-vessel disease].[三种策略对真实世界中三支血管病变稳定型冠心病患者的疗效比较]
Zhonghua Xin Xue Guan Bing Za Zhi. 2017 Dec 24;45(12):1049-1057. doi: 10.3760/cma.j.issn.0253-3758.2017.12.009.
6
New-Onset Atrial Fibrillation After PCI or CABG for Left Main Disease: The EXCEL Trial.左主干疾病行经皮冠状动脉介入治疗或冠状动脉旁路移植术后新发心房颤动:EXCEL 试验。
J Am Coll Cardiol. 2018 Feb 20;71(7):739-748. doi: 10.1016/j.jacc.2017.12.012.
7
Long-term Outcomes in Patients With Severely Reduced Left Ventricular Ejection Fraction Undergoing Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting.经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗左心室射血分数严重降低患者的长期预后
JAMA Cardiol. 2020 Jun 1;5(6):631-641. doi: 10.1001/jamacardio.2020.0239.
8
Multiple Arterial Grafting Is Associated With Better Outcomes for Coronary Artery Bypass Grafting Patients.多支动脉搭桥术与冠状动脉旁路移植术患者的更好结局相关。
Circulation. 2018 Nov 6;138(19):2081-2090. doi: 10.1161/CIRCULATIONAHA.118.034464.
9
Impact of diabetes mellitus on patients with unprotected left main coronary artery lesion disease treated with either percutaneous coronary intervention or coronary-artery bypass grafting.糖尿病对接受经皮冠状动脉介入治疗或冠状动脉旁路移植术的无保护左主干冠状动脉病变患者的影响。
Coron Artery Dis. 2012 Aug;23(5):322-9. doi: 10.1097/MCA.0b013e3283564961.
10
[Prognostic analysis of drug-eluting stent implantation and coronary artery bypass grafting in patients with unprotected left main coronary artery disease complicated with chronic renal failure].[药物洗脱支架植入术与冠状动脉旁路移植术治疗无保护左主干冠状动脉疾病合并慢性肾衰竭患者的预后分析]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Oct;32(10):1203-1207. doi: 10.3760/cma.j.cn121430-20200518-00391.

本文引用的文献

1
Effect of Adding Ticagrelor to Standard Aspirin on Saphenous Vein Graft Patency in Patients Undergoing Coronary Artery Bypass Grafting (POPular CABG): A Randomized, Double-Blind, Placebo-Controlled Trial.替格瑞洛联合标准阿司匹林对冠状动脉旁路移植术患者隐静脉桥通畅率的影响(POPular CABG):一项随机、双盲、安慰剂对照试验。
Circulation. 2020 Nov 10;142(19):1799-1807. doi: 10.1161/CIRCULATIONAHA.120.050749. Epub 2020 Aug 31.
2
Is Peripheral Artery Disease an Independent Predictor of Isolated Coronary Artery Bypass Outcome?外周动脉疾病是否是单纯冠状动脉旁路移植术结局的独立预测因子?
Heart Lung Circ. 2020 Oct;29(10):1502-1510. doi: 10.1016/j.hlc.2020.01.013. Epub 2020 Feb 25.
3
2018 ESC/EACTS Guidelines on myocardial revascularization.
2018年欧洲心脏病学会/欧洲心胸外科学会心肌血运重建指南。
Eur Heart J. 2019 Jan 7;40(2):87-165. doi: 10.1093/eurheartj/ehy394.
4
Prognostic implications of peripheral artery disease in coronary artery disease.外周动脉疾病对冠状动脉疾病预后的影响。
Curr Opin Pharmacol. 2018 Apr;39:121-128. doi: 10.1016/j.coph.2018.04.005.
5
Systematic detection of polyvascular disease combined with aggressive secondary prevention in patients presenting with severe coronary artery disease: The randomized AMERICA Study.严重冠状动脉疾病患者中联合强化二级预防的多血管病变的系统检测:随机 AMERICA 研究。
Int J Cardiol. 2018 Mar 1;254:36-42. doi: 10.1016/j.ijcard.2017.11.081. Epub 2018 Jan 28.
6
2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS).2017年欧洲心脏病学会(ESC)与欧洲血管外科学会(ESVS)合作制定的外周动脉疾病诊断和治疗指南:涵盖颅外颈动脉和椎动脉、肠系膜、肾、上肢和下肢动脉粥样硬化疾病的文件 认可机构:欧洲卒中组织(ESO) 欧洲心脏病学会(ESC)和欧洲血管外科学会(ESVS)外周动脉疾病诊断和治疗特别工作组
Eur Heart J. 2018 Mar 1;39(9):763-816. doi: 10.1093/eurheartj/ehx095.
7
Prolonged vs Short Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With or Without Peripheral Arterial Disease: A Subgroup Analysis of the PRODIGY Randomized Clinical Trial.经皮冠状动脉介入治疗患者双联抗血小板治疗时间长短与外周动脉疾病:PRODIGY 随机临床试验的亚组分析。
JAMA Cardiol. 2016 Oct 1;1(7):795-803. doi: 10.1001/jamacardio.2016.2811.
8
Symptomatic peripheral artery disease is associated with decreased long-term survival after coronary artery bypass: a contemporary retrospective analysis.症状性外周动脉疾病与冠状动脉搭桥术后长期生存率降低相关:一项当代回顾性分析。
Surg Today. 2016 Nov;46(11):1334-40. doi: 10.1007/s00595-016-1379-4. Epub 2016 Jul 21.
9
The prevalence of abdominal aortic aneurysm is consistently high among patients with coronary artery disease.腹主动脉瘤在冠状动脉疾病患者中的患病率一直很高。
J Vasc Surg. 2015 Jul;62(1):232-240.e3. doi: 10.1016/j.jvs.2015.02.037.
10
Epidemiology of peripheral artery disease.外周动脉疾病的流行病学。
Circ Res. 2015 Apr 24;116(9):1509-26. doi: 10.1161/CIRCRESAHA.116.303849.